•   
  •   
  •   

Health & Fit Alzheimer's: New research examines disease in women

16:51  23 july  2018
16:51  23 july  2018 Source:   cnn.com

Warning, These Common Medications May Raise Your Risk of Dementia

  Warning, These Common Medications May Raise Your Risk of Dementia Ag study published in the British Medical Journal reveals that use of one group of anticholinergenics prescribed to treat depression, bladder control problems, and Parkinson’s disease—appear to raise the risk of dementia,If you feel like you’re foggy after taking Benadryl, Nyquil, ZzzQuil, Unisom, or other medication that contains diphenhydramine, you’re not imagining it. Known as anticholinergics, these meds can sometimes cause mental confusion.

At the Alzheimer ' s Association International Conference, researchers are exploring biological and social differences that might explain why more women than men develop dementia.

Alzheimer ’ s disease is currently ranked as the sixth leading cause of death in the United States, but recent estimates indicate that the disorder may rank Alzheimer ’ s disease is named after Dr. Alois Alzheimer . In 1906, Dr. Alzheimer noticed changes in the brain tissue of a woman who had died of

Elderly woman with walker in a hallway, black and white © Shutterstock Elderly woman with walker in a hallway, black and white At the Alzheimer's Association International Conference in Chicago this week, researchers are exploring biological and social differences that might explain why more women than men develop Alzheimer's and other types of dementia.

A study to be presented at the conference found a link between a lower risk for dementia and the number of births a woman has. Women with three or more children had a 12% lower risk of developing cognitive issues than a woman with only one child, according to initial results of the study of nearly 15,000 women. Pregnancy failures, however, increased a woman's risk, according to the Kaiser Permanente study. Compared with women who never lost a pregnancy, women with three or more miscarriages had a 47% higher risk for dementia.

UK, US drugmakers scrap 'futile' Alzheimer's treatment trial

  UK, US drugmakers scrap 'futile' Alzheimer's treatment trial British and American pharmaceutical giants AstraZeneca and Eli Lilly on Tuesday said they were ending a large clinical trial of a treatment for Alzheimer's that they had been developing jointly. The decision to scrap the phase III clinical trial comes as a major setback in the race to find a cure for the disease, which is the most common form of dementia and affects millions of people around the world.With a clinical trial failure rate of over 99 percent, there is still no licenced drug that slows Alzheimer's progression or cures it.

New Alzheimer ’ s Association Grant Will Help Researchers Explore That Question. SAGA was made possible from the generous support of the Women 's Alzheimer ' s Research Initiative (WARI), a campaign that supports research grants specific to sex-biology and gender issues in Alzheimer ’ s

Despite many promising leads, new treatments for Alzheimer ' s are slow to emerge. In one study, taking estrogen-based hormone therapy for at least a year during perimenopause or early menopause appeared to protect thinking and memory in women with a higher risk of Alzheimer ' s disease .

It's just one of several studies at the conference looking at how pregnancy, female hormones, age of menarche and menopause, and even a woman's innate cognitive advantages might affect her risk for the condition.

A woman's disease

Alzheimer's is a progressive mental deterioration of the brain that destroys memory and thinking skills until the person is unable to do even the simplest of tasks. The disease is thought to be caused by a buildup in the brain of beta amyloid plaques and neurofibrillary tangles called tau.

Of the approximately 50 million people around the world living with dementia and Alzheimer's, most are women. In the US alone, two-thirds of the 5.7 million Americans living with Alzheimer's are female. Women 60 and older are twice as likely to be diagnosed with Alzheimer's as breast cancer.

New evidence that viruses may play a role in Alzheimer's

  New evidence that viruses may play a role in Alzheimer's Viruses that sneak into the brain just might play a role in Alzheimer's, scientists reported Thursday in a provocative study that promises to re-ignite some long-debated theories about what triggers the mind-robbing disease. (Mount Sinai Health System via AP) WASHINGTON — Viruses that sneak into the brain just might play a role in Alzheimer's, scientists reported Thursday in a provocative study that promises to re-ignite some long-debated theories about what trig The findings don't prove viruses cause Alzheimer's, nor do they suggest it's contagious.

Alzheimer ' s disease is the most common type of dementia. Alzheimer ’ s disease is a condition that affects the brain. The symptoms are mild at first and become more severe over time. READ MORE. Anxiety may be an early sign of Alzheimer ' s . New research has linked increasing symptoms of

Alzheimer ' s Prevalence Among Women . Women entering their twilight years face an increased risk of a handful of ailments, including osteoporosis, for which The team said their findings support the use of statin medications, which includes Lipitor, in the prevention of heart attacks and stroke in women .

The results are devastating. The World Health Organization calls dementia one of the top 10 global causes of death for women. In the US, Alzheimer's is now the sixth leading cause of death, killing more seniors than breast cancer and prostate cancer combined. In England, Wales and Australia, 2016 death statistics show that dementia and Alzheimer's kill more women than heart disease.

Yet for many years, experts say, science wasn't focused on why Alzheimer's affects more women than men.

"Age is the greatest predictor of Alzheimer's, so for a long time, there was this notion that women are at higher risk only because they live longer," said University of Illinois psychology and psychiatry professor Pauline Maki, who is presenting at the Alzheimer's conference. "No one was paying attention to what was going on in the female brain throughout a woman's life."

"I was requesting grant money to research estrogen, and I was getting comments from reviewers asking, 'Why are you doing this?' " said presenter Carey Gleason of the Wisconsin Alzheimer's Disease Research Center.

Here’s Why You Should Never Wash Chicken Before Cooking It

  Here’s Why You Should Never Wash Chicken Before Cooking It You probably think you're washing germs or sliminess from the chicken — nope, you're doing a lot worse than that.It’s the most polarizing problem in poultry—should you wash your chicken before cooking it? Food health and safety professionals are advising against this practice, as it can increase the spread of bacteria and the risk of cross-contamination. Don’t miss these other cooking mistakes that can make your food toxic.

New Alzheimer ’ s Association Supported Studies. • Almost 2/3 of Americans with Alzheimer ’ s disease are women . need sex-specific test “cut points” to improve early detection in women • Results may guide women ’s healthcare during and after the menopausal transition and help women make

Alzheimer ' s disease causes about 70% of cases of dementia.1 In the Framingham study, Bachman and colleagues reported that the incidence of Alzheimer ' s AD is named after Dr Alois Alzheimer , who first observed the disease in 1901 in a 51-year-old woman named Augusta D, who experienced

Over the past few years, that's been changing.

"We're at a very exciting time in the field," said Rachel Whitmer, professor of public health sciences at the UC Davis School of Medicine. "Rather than just brushing it aside as 'women live longer and that's the end of story,' science is now breaking it down to a deeper level to understand the where, when, why and how."

Role of reproductive life

The Kaiser Permanente study, which looked at number of births and dementia risk, followed women who have used the company's health care most of their lives. This allowed researchers to access each woman's medical records between 1964 and 1973 and then again from 1996 to 2017.

That was important, the researchers said, because they weren't relying on a woman's memory of her reproductive and medical history, a key flaw in many study designs.

"I myself have trouble sometimes with remembering what happened last week," said Whitmer, who co-led the study. "But we actually have the questionnaires they filled out from the '60s and '70s."

"We could then compare that to their midlife risk factors such as hypertension, stroke, diabetes and heart disease and factor those out," added Paola Gilsanz, a staff scientist at Kaiser Permanente who co-led the study. "So in that sense, it's very, very powerful."

Bill Gates and a group of investors are backing a $30 million 'venture philanthropy' fund to tackle Alzheimer's

  Bill Gates and a group of investors are backing a $30 million 'venture philanthropy' fund to tackle Alzheimer's Along with a group of philanthropists, Bill Gates is sinking $30 million into the Diagnostics Accelerator, a "venture philanthropy" fund to develop early diagnostic procedures and bring them to market quickly Last November, Gates made an initial $50 million investment into Alzheimer's research. Now, Gates is teaming up with a group of philanthropists including Leonard Lauder and the Charles and Helen Schwab Foundation to sink another $30 million into a bold new idea for diagnosing Alzheimer's earlier — which is one of the keys to developing drugs to treat the disease.

When the study began in 1964, all of the women were 40 to 55. Their medical records documented reproductive history, education, race and midlife health status, as well as when each woman began menstruating, when she went into menopause and the length of those reproductive years. Dementia diagnosis and later-life chronic conditions, such as heart failure and diabetes, were pulled from records between 2016 and 2017.

In addition to finding that multiple pregnancies were protective against dementia but multiple miscarriages were not, the study found that women who were fertile for only 21 to 30 years had a 33% higher risk for dementia than women who were fertile for a longer time period.They also found that women who started their first menstrual cycle at 16 or older were 31% more likely to have cognitive problems than women who began at age 13.

What do all of these results mean? It's too early to tell, Whitmer said.

"This is an observational study," she said. "It doesn't tell you the mechanisms, but it's telling you who is at higher and lower risk. This information allows basic scientists to take the next step and do more experimental work and really delve in."

The Kaiser study conflicted with recently published research that found South Korean and Greek women who have given birth five or more times may be 70% more likely to develop Alzheimer's later in life.

8 Weird Things Linked to Memory Loss Later in Life

  8 Weird Things Linked to Memory Loss Later in Life These lesser known factors may affect your risk of dementia, or serve as an early warning sign.But there are lots of other factors that can affect your risk of dementia or age-related memory loss. Some are obvious (like genetics). Others are less so. Here are a few that might surprise you.

"Korean, Greek and American women are pretty different genetically," said Alzheimer's researcher Dr. Richard Isaacson, who was not involved in either study. "You have to be very careful with generalizing these studies. Take for example, studies done in China on stroke. You can't generalize those findings to stroke patients in the United States unless they're Chinese American or born in China and moved here.

"Alzheimer's disease is a life course disease in my opinion," said Isaacson, who founded the Alzheimer's Prevention Clinic at NewYork-Presbyterian/Weill Cornell Medical Center. "The risk starts in the womb and is then affected by your genes, your early life risk factors, your educational attainment, your diet and exercise and so much more."

Better cognitive assessment

A new study released claims scientists in Australia and Japan have developed a new blood test to detect the early stages of Alzheimer's disease. © Florey Institute/University of Melbourne A new study released claims scientists in Australia and Japan have developed a new blood test to detect the early stages of Alzheimer's disease. Another study presented at the conference focused on the need for more accurate screening tests for Alzheimer's -- tests that would consider a woman's innate advantage over men in verbal memory.

"If you go to the store without your grocery list, a woman is going to do the better job of remembering it," said Maki, who led the study. "A man will be better at visual-spatial things, like finding the way home."

Cognitive tests used to diagnose Alzheimer's rely heavily on recalling word lists, stories and other verbal materials. That means women who have mild cognitive decline can score as normal, Maki said, thus keeping them from possibly beginning medication and making appropriate lifestyle changes. It could also mean that some men might get a false positive on the memory test, she said, and be diagnosed with brain changes when they are actually normal.

Alzheimer's Genes: Are You at Risk?

  Alzheimer's Genes: Are You at Risk? Researchers have identified a number of genes associated with Alzheimer's disease. However, genetic risk factors are just one of the factors involved in getting Alzheimer's disease.Genes control the function of every cell in your body. Some genes determine basic characteristics, such as the color of your eyes and hair. Other genes can make you more likely to develop certain diseases, including Alzheimer's disease.

Using data from the Alzheimer's Disease Neuroimaging Initiative, a multicenter study designed to develop biomarkers for Alzheimer's, Maki found that women performed better even when they had the same level of disease as a man. It also took high levels of disease for that advantage to be eliminated. This could explain, she said, why women seem to deteriorate faster than men after diagnosis: They are further along in the disease.

Maki then tested a new scoring mechanism for the Alzheimer's memory test, making it harder for women to get a "passing grade" while making it easier for men. She found that 10% of women who showed Alzheimer's pathology on brain scans could now be identified; she also found that 10% of men who would have been considered cognitively deficient now ranked normal.

"More research is needed to apply these results to larger populations," Maki said, "but it shows the need for a re-evaluation of the tests we use to diagnose Alzheimer's so both men and women can get the help they need."

The role of estrogen

A third study at the conference, presented by Gleason of the Wisconsin Alzheimer's Disease Research Center, looked at more recent studies on the cognitive effects of hormone replacement therapy, a topic with a controversial history.

"We're recognizing that our models were too simplistic," she said, "and that there's a lot more things to pay attention to, including a woman's underlying health, genetic profile and the timing of when hormone replacement therapy is started and stopped."

For years, science believed that giving women hormone replacement therapy, or HRT, at menopause was beneficial for the aging brain and would help prevent heart disease. But then came shocking preliminary results from the Women's Health Initiative, a long-term national study designed to look at ways to prevent heart disease, osteoporosis and breast and colon cancer in women.

Herpes May Cause 50 Percent of Alzheimer's Cases: Study

Herpes May Cause 50 Percent of Alzheimer's Cases: Study Antiviral medication could prevent the development of Alzheimer's, according to Professor Ruth Itzhaki.

Those 2002 and 2004 results found that the estrogen-progesterone combo of HRT actually increased the risk for heart disease as well as stroke, blood clots, dementia and breast cancer.

The use of HRT plummeted. Then, 10 years later, the Women's Health Initiative reversed its findings. Because the original analysis looked at older women, who were already at risk for heart attacks, blood clots and stroke, the initial results were flawed because they failed to consider a woman's age at the start of replacement therapy.

Today, it's believed that HRT could be helpful in controlling menopausal symptoms at the time when most women undergo the change, in their late 40s and early 50s, when their risk for chronic disease is lower.

Women who wish to take hormones later in life, when the risk for blood clots, stroke and cancer is higher, should look at their risk factors and discuss the option carefully with their doctor.

HRT also might not help the older brain: Women who start hormone therapy in their 70s, said Gleason, showed persistent declines in cognition, working memory and the ability to organize and get things done, which is called executive functioning.

For younger women, Gleason said, more recent research has found no cognitive harm or benefit to several forms of HRT if started within a few years of menopause, unless the woman has Type 2 diabetes.

"If you're a diabetic, you're at increased risk to progress to dementia, period," she said. "But the risk is bigger if you're on hormone therapy."

It's complex and often confusing, but researchers in the field say that all signs point to more definitive answers within the next five years.

"We need a personalized medicine approach to menopausal hormone therapy," Gleason said. "We are in a really exciting time in terms of understanding the complexity of estrogen, menopause and menopausal hormone therapy and how all of these things combine."

"No one size fits all," agreed Isaacson. "We need to use imaging, biomarkers, blood biomarkers, clinical history, such as when they started their menstrual period, when they stopped. Different women are going to need different therapeutic interventions. This will be precision medicine at its finest."

Herpes May Cause 50 Percent of Alzheimer's Cases: Study.
Antiviral medication could prevent the development of Alzheimer's, according to Professor Ruth Itzhaki.

Topical videos:

usr: 1
This is interesting!